|
HY-136135-100mg
|
MedChemexpress LLC
|
(2-pyridyldithio)-PEG1-hydrazine [CAS 111625-28-6]
|
|
Cancer-programmed cell death
|
|
|
HY-136135-250mg
|
MedChemexpress LLC
|
(2-pyridyldithio)-PEG1-hydrazine [CAS 111625-28-6]
|
|
Cancer-programmed cell death
|
|
|
HY-135964-100mg
|
MedChemexpress LLC
|
(2-pyridyldithio)-PEG4 acid [CAS 581065-93-2]
|
|
Cancer-programmed cell death
|
|
|
HY-135964-50mg
|
MedChemexpress LLC
|
(2-pyridyldithio)-PEG4 acid [CAS 581065-93-2]
|
|
Cancer-programmed cell death
|
|
|
HY-W002680-1g
|
MedChemexpress LLC
|
(2R,4R)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate [CAS 114676-69-6]
|
|
Cancer-programmed cell death
|
|
|
HY-W002680-5g
|
MedChemexpress LLC
|
(2R,4R)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate [CAS 114676-69-6]
|
|
Cancer-programmed cell death
|
|
|
HY-76104-1g
|
MedChemexpress LLC
|
(2R,4R)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride [CAS 77449-94-6]
|
|
Cancer-programmed cell death
|
|
|
HY-76104-5g
|
MedChemexpress LLC
|
(2R,4R)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride [CAS 77449-94-6]
|
|
Cancer-programmed cell death
|
|
|
HY-77593-1g
|
MedChemexpress LLC
|
(2R,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid [CAS 147266-92-0]
|
|
Cancer-programmed cell death
|
|
|
HY-77593-100mg
|
MedChemexpress LLC
|
(2R,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid [CAS 147266-92-0]
|
|
Cancer-programmed cell death
|
|
|
HY-77593-5g
|
MedChemexpress LLC
|
(2R,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid [CAS 147266-92-0]
|
|
Cancer-programmed cell death
|
|
|
HY-77593-500mg
|
MedChemexpress LLC
|
(2R,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid [CAS 147266-92-0]
|
|
Cancer-programmed cell death
|
|
|
HY-W017882-1g
|
MedChemexpress LLC
|
(2R,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate [CAS 135042-17-0]
|
|
Cancer-programmed cell death
|
|
|
HY-W017882-5g
|
MedChemexpress LLC
|
(2R,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate [CAS 135042-17-0]
|
|
Cancer-programmed cell death
|
|
|
HY-145397-10mg
|
MedChemexpress LLC
|
(4-NH2)-Exatecan [CAS 2495742-21-5]
|
|
Cancer-programmed cell death
|
|
|
HY-145397-25mg
|
MedChemexpress LLC
|
(4-NH2)-Exatecan [CAS 2495742-21-5]
|
|
Cancer-programmed cell death
|
|
|
HY-145397-5mg
|
MedChemexpress LLC
|
(4-NH2)-Exatecan [CAS 2495742-21-5]
|
|
Cancer-programmed cell death
|
|
|
HY-145397-50mg
|
MedChemexpress LLC
|
(4-NH2)-Exatecan [CAS 2495742-21-5]
|
|
Cancer-programmed cell death
|
|
|
HY-W017755-1g
|
MedChemexpress LLC
|
(R)-Azetidine-2-carboxylic acid [CAS 7729-30-8]
|
|
Cancer-programmed cell death
|
|
|
HY-W017755-100mg
|
MedChemexpress LLC
|
(R)-Azetidine-2-carboxylic acid [CAS 7729-30-8]
|
|
Cancer-programmed cell death
|
|
|
HY-W017755-500mg
|
MedChemexpress LLC
|
(R)-Azetidine-2-carboxylic acid [CAS 7729-30-8]
|
|
Cancer-programmed cell death
|
|
|
HY-128355A-1mg
|
MedChemexpress LLC
|
(R)-IDO/TDO-IN-1 [CAS 2033173-00-9]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-128355A-10mg
|
MedChemexpress LLC
|
(R)-IDO/TDO-IN-1 [CAS 2033173-00-9]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-128355A-100mg
|
MedChemexpress LLC
|
(R)-IDO/TDO-IN-1 [CAS 2033173-00-9]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-128355A-25mg
|
MedChemexpress LLC
|
(R)-IDO/TDO-IN-1 [CAS 2033173-00-9]
|
|
Metabolism-protein/nucleotide metabolism
|
|
